Treating seasonal spikes as isolated crises traps healthcare systems in a reactive cycle rather than a proactive one. Explore how learnings from recent “tripledemics” of flu, RSV and COVID-19 can inform a more sustainable sampling model for URI management.

Dr. Wadman joins PSQH: The Podcast to discuss how challenges he personally faced with nasal swab sampling at the start of the pandemic inspired new innovations in evolved nasal lavage. He highlights how MicroWash delivers more comfortable and sensitive specimens to support future outbreak containment. Tune in to the episode.

Patient discomfort from nasal swabs drives testing avoidance, undermining early diagnosis, treatment and outbreak control for URIs. Evolved nasal lavage offers a safer, more tolerable alternative that delivers higher-sensitivity samples, simplifies clinical use and strengthens public health readiness. MicroWash is setting the new collection standard.

Where and how we collect pathogen-containing material for URI testing can make the difference between a confirmed infection and a missed case. Dive into the science behind why evolved nasal lavage solutions like MicroWash produce higher-sensitivity samples compared to the swab — and why that matters for more effective treatment and outbreak response.

Dr. Nguyen, the lead designer and developer of MicroWash, recently received the esteemed FIPICA distinction. This award recognizes faculty who have successfully nurtured significant intellectual property from concept to licensing.

In an article for MedCity News, Dr. Wadman sheds light on the “why” behind post-pandemic URI testing avoidance. As nasal swabs continue to deter patients due to discomfort, injury risks and other complications, explore how evolved nasal lavage methods like MicroWash could be a key solution for boosting testing volumes.

Nasal swab specimen collection remains the default for URI testing — but its safety, sensitivity and scalability often fall short. Explore key risks for patients, providers and labs, and see why evolved nasal lavage solutions are a more reliable collection method for today’s testing demands.

Dr. Wadman recently authored an article for Patient Safety & Quality Healthcare highlighting the need to adapt specimen collection for modern URI testing. He explores how evolved nasal lavage provides safer and more comfortable sampling with higher sensitivity, addressing nasal swab limitations while enhancing outbreak readiness.

With MicroWash now commercially available for U.S. healthcare providers, Silicon Prairie News featured two of the biggest innovators behind it. Dr. Wadman and Dr. Nguyen shared how their experience on the COVID-19 frontlines led to a more scalable, safe and sensitive nasal sampling approach compared to the swab.

Nasal swabs were the go-to sampling method during COVID-19 — but at what cost? Broken-off swabs, inconsistent specimen quality and human error took a toll on automation. Take a closer look at what’s really slowing labs down, and how evolved nasal lavage solutions can seamlessly help you achieve higher throughput.